4-[(5R*,10bR*)-2-Methyl-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazin-5-yl]benzoic acid
Authors:
Open Access
- 6 February 2008
- journal article
- other
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section E Structure Reports Online
- Vol. 64 (3) , o563
Abstract
In the title compound, C(18)H(16)N(2)O(3), a potential inhibitor of the cyclo-oxygenase-2 isoenzyme, the pyrazoline ring exists in a flattened envelope conformation with one C atom deviating by 0.463 Å from the mean plane of the remaining four atoms. The puckering of the central oxazine ring is more severe, with one N atom and one C atom displaced by 0.235 (6) and 0.370 (2) Å, respectively, on opposite sides of the mean plane defined by the other four atoms; the conformation is that of a half-chair. As a result, the mol-ecule as a whole is not planar. The carboxyl group is involved in an inter-molecular O-H⋯N hydrogen bond, which links the mol-ecules into centrosymmetric dimers.Keywords
This publication has 5 references indexed in Scilit:
- A short history of SHELXActa Crystallographica Section A Foundations of Crystallography, 2007
- Synthesis of some pyrazolo[1,5-c][1,3]benzoxazines and a new 5H-pyrazolo[1,5-c][1,3,2]benzoxazaphosphorine ring systemJournal of Heterocyclic Chemistry, 2005
- Single-crystal structure validation with the programPLATONJournal of Applied Crystallography, 2003
- Cyclooxygenase-2 Is Overexpressed in HER-2/neu-positive Breast CancerJournal of Biological Chemistry, 2002
- Identification of Novel Cyclooxygenase-2 Selective Inhibitors Using Pharmacophore ModelsJournal of Medicinal Chemistry, 2002